Skip to main content
Top

Journal of Cancer Research and Clinical Oncology

Issue 7/2005

Content (9 Articles)

Review

70 Gy or more: which dose for which prostate cancer?

U. Ganswindt, F. Paulsen, A. G. Anastasiadis, A. Stenzl, M. Bamberg, C. Belka

Original Paper

The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status

Wolfgang J. Köstler, Thomas Brodowicz, Gernot Hudelist, Margaretha Rudas, Reinhard Horvat, Günther G. Steger, Christian F. Singer, Johannes Attems, Werner Rabitsch, Negar Fakhrai, Katarzyna Elandt, Christoph Wiltschke, Michael Hejna, Christoph C. Zielinski

Original Paper

Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization

Shuang-Jian Qiu, Lina Lu, Chunping Qiao, LiangFu Wang, Zhong Wang, Xiao Xiao, Shiguang Qian, John J. Fung, Sheng-Long Ye, C. Andrew Bonham

Original Paper

Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women

Malin Bergman, Marie Ahnström, Pia Palmebäck Wegman, Sten Wingren

Original Paper

Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma

Ken Nakatani, Takeshi Wada, Megumi Nakamura, Katsuhiro Uzawa, Hideki Tanzawa, Shigeyuki Fujita

Original Paper

Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma

T. Valković, D. Fučkar, S. Štifter, K. Matušan, M. Hasan, F. Dobrila, N. Jonjić

Original Paper

Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response

Jianping Pan, Minghui Zhang, Jianli Wang, Qingqing Wang, Dajing Xia, Wenji Sun, Lihuang Zhang, Hai Yu, Xuetao Cao

Original Paper

Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC)

Dorota Dworakowska, Ewa Jassem, Jacek Jassem, Carsten Boltze, Klaus Hermann Wiedorn, Rafał Dworakowski, Jan Skokowski, Kazimierz Jaśkiewicz, Eugenia Częstochowska

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine